Complex Trauma and Grief Case Review

Sabrina Mesiemore (45F)

DOB: 05/23/1980 | Visit: March 9, 2026

Collaborating Provider: Stacy Pascarella, APRN

Reviewer: Psychiatric MD Collaborator | March 19, 2026

Assessment: Reasonable Course with Enhancements

1 / 10

Diagnostic Formulation: 5+1 Diagnoses

DiagnosisCodeStatus
PTSD, Chronic SevereF43.10✅ Appropriate
Prolonged Grief DisorderF43.81✅ Appropriate
Bipolar Disorder, DepressedF31.4✅ Appropriate
Panic DisorderF41.0⚠️ Modify — In remission
Other Specified AnxietyF41.8✅ Appropriate
Additional: Nightmare Disorder (F51.5) — specify separately for targeted treatment
2 / 10

Medication Regimen Review

MedicationAssessmentAction
FluvoxamineReasonableContinue
Vraylar (cariprazine)ReasonableContinue; monitor metabolic
Lamictal (taper)⚠️ Requires modificationSuspend taper
Nightmare treatmentGap identifiedInitiate trial
Critical: Lamictal taper during EMDR = mood destabilization risk in bipolar patient
3 / 10

Critical Issue #1: Suspend Lamictal Taper

Current Plan: Taper lamotrigine

Recommendation: Suspend until EMDR complete

Rationale:

  • EMDR activates trauma processing → emotional dysregulation
  • Lamotrigine taper → reduced mood stabilization
  • Combined effect = high manic/hypomanic switch risk
  • Bipolar patients require mood stability during trauma therapy
Timeline: Resume taper 8+ weeks post-EMDR completion with mood stability confirmed
4 / 10

Critical Issue #2: Metabolic Monitoring

BMI 33.94 on Cariprazine

Metabolic syndrome risk requires active monitoring

Required Monitoring:

  • Fasting glucose
  • HbA1c
  • Lipid panel (fasting)
  • Weight/BMI tracking
Frequency: Baseline, 12 weeks, then annually (or quarterly if metabolic risk)
5 / 10

Critical Issue #3: Sleep Stabilization Before EMDR

EMDR Prerequisites:

  1. Sleep study reviewed and addressed
  2. Nightmare pharmacology trial initiated
  3. 8+ weeks mood stability confirmed
  4. EMDR provider bipolar experience verified

Nightmare Treatment Options:

  • Prazosin rechallenge 1mg
  • Gabapentin 300-600mg at bedtime
  • Topiramate 25-50mg (mood stabilizing benefit)
6 / 10

Psychotherapy Integration

ModalityStatusNotes
Supportive/humanistic✅ ContinueStrong therapeutic alliance
EMDR⏳ ConditionalPending sleep/mood stability
CGT💡 Consider16-session protocol for prolonged grief
CBT-I💡 ConsiderIf insomnia persists
Self-Compassion Homework: Excellent — well-constructed letter targeting core shame
7 / 10

Integrated Care Coordination

Additional Care Needs:

  • Chronic pain: CBT-CP referral; trauma-informed physical therapy
  • Caregiver burden: Respite resources, Area Agency on Aging
  • Nutrition: Referral given BMI 33.94 + family history
  • Safety: C-SSRS during trauma treatment phase
Behavioral Activation Success: Spontaneous pool visit — leverage this positive momentum
8 / 10

Follow-up Timeline

WhenActionWho
2 weeksReview sleep study; start nightmare medsAPRN/PCP
4 weeksMood stability check; metabolic labsAPRN/MD
6 weeksReassess sleep/nightmaresAPRN
8 weeksEMDR initiation if clearedEMDR provider
OngoingWeekly therapy; biweekly psych checksAPRN/MD
9 / 10

Summary: Reasonable Course, Specific Enhancements

Current Course: APPROVED

Priority: Suspend Lamictal taper, stabilize sleep, then EMDR

Next Steps:

  1. Suspend lamotrigine taper immediately
  2. Obtain and address sleep study
  3. Initiate nightmare pharmacology trial
  4. Confirm 8-week mood stability before EMDR
  5. Verify EMDR provider bipolar experience

From: Psychiatric MD Collaborator | To: Stacy Pascarella, APRN
March 19, 2026

10 / 10